InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28+ MET PODLOGAR SUSAN M EVP, Chief HR Off F - Tax $71.67 -15.2K 66.5K -19% -$1.09M
DM 2023-03-02 2023-02-28 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant — +33.6K 79.7K +73% —
D 2023-03-02 2023-02-28 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant $0.00 +11.0K 11.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 1,981 $71.27 64,542 D — —
2 Common Common Stock 2023-02-28 F D 13,223 $71.73 66,523 D — —
3 Common Common Stock 2023-02-28 A A 3,660 — 49,853 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Common Common Stock 2023-02-28 A A 29,893 — 79,746 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 10,979 $0.00 10,979 D $71.73 · — to 2033-02-27 10,979 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.